Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Single-blind, Randomized, Controlled Study of the Safety and Effectiveness of JUVÉDERM VOLBELLA® XC Injectable Gel for Correction of Infraorbital Hollowing

NCT03418545 is registered in ClinicalTrials.gov with Allergan as lead sponsor.

NCT NCT03418545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03418545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Single-blind, Randomized, Controlled Study of the Safety and Effectiveness of JUVÉDERM VOLBELLA® XC Injectable Gel for Correction of Infraorbital Hollowing
Lead sponsor
Allergan
Phase
Phase 3
Overall status
Completed
Start date
January 26, 2018
Completion date
August 22, 2019
Enrollment
163 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

infraorbital hollowing